JACOBS LEVY EQUITY MANAGEMENT, INC

Position in VIR — Vir Biotechnology, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,389,253

-$11,534,077 QoQ

Shares Held

136,335

-90.5% QoQ

Ownership

0.081%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#75

of 237 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $740,535,030 across 80 Biotechnology names. VIR ranks #49 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,389,253	136,335	-90.5%	Shares	Sole	2026-08-14
2026-03-31	$12,923,330	1,442,336	+1391.3%	Shares	Sole	2026-05-15
2025-09-30	$552,254	96,717	-33.4%	Shares	Sole	2025-11-17
2025-06-30	$732,301	145,298	+162.0%	Shares	Sole	2025-08-14
2025-03-31	$359,328	55,452	-84.2%	Shares	Sole	2025-05-15
2024-09-30	$2,623,484	350,265	+10.6%	Shares	Sole	2024-11-14
2024-06-30	$2,819,448	316,792	+2.2%	Shares	Sole	2024-08-14
2024-03-31	$3,141,221	310,091	+5.7%	Shares	Sole	2024-05-15
2023-12-31	$2,952,368	293,476	+4.6%	Shares	Sole	2024-02-14
2023-09-30	$2,629,222	280,600	+1363.8%	Shares	Sole	2023-11-17
2022-09-30	$369,578	19,169	—	Shares	Sole	2022-11-15
No filing history on record for this holder in this stock.